Lorna Bozeman

3.3k total citations · 1 hit paper
26 papers, 2.4k citations indexed

About

Lorna Bozeman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Lorna Bozeman has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 14 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Lorna Bozeman's work include Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (9 papers) and Diagnosis and treatment of tuberculosis (6 papers). Lorna Bozeman is often cited by papers focused on Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (9 papers) and Diagnosis and treatment of tuberculosis (6 papers). Lorna Bozeman collaborates with scholars based in United States, Uganda and Canada. Lorna Bozeman's co-authors include William J. Burman, Awal Khan, Marc Weiner, Margarita E. Villarino, Richard E. Chaisson, Debra Benator, Andrew Vernon, Nong Shang, C. Robert Horsburgh and Fred M. Gordin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Lorna Bozeman

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

2011 630 citations Timothy R. Sterling, Margarita E. Villarino et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorna Bozeman United States	18	2.0k	1.7k	903	194	147	26	2.4k
Tine De Marez United States	12	1.2k 0.6×	869 0.5×	345 0.4×	321 1.7×	28 0.2×	17	1.6k
Kai Man Kam China	28	2.0k 1.0×	1.7k 1.0×	760 0.8×	505 2.6×	11 0.1×	82	3.1k
Mónica Galiano United Kingdom	23	2.0k 1.0×	1.5k 0.9×	186 0.2×	318 1.6×	604 4.1×	40	3.2k
S. R. Pattyn Belgium	22	1.0k 0.5×	1.2k 0.7×	185 0.2×	300 1.5×	27 0.2×	96	2.1k
Bone S. F. Tang Hong Kong	24	1.2k 0.6×	635 0.4×	152 0.2×	207 1.1×	256 1.7×	35	1.9k
Julie Greensill United Kingdom	17	785 0.4×	873 0.5×	187 0.2×	87 0.4×	38 0.3×	19	1.4k
Christopher D. Huston United States	28	1.8k 0.9×	286 0.2×	905 1.0×	370 1.9×	78 0.5×	68	2.5k
Hassan Zaraket Lebanon	31	1.2k 0.6×	1.5k 0.9×	137 0.2×	482 2.5×	134 0.9×	100	2.5k
José A. Caminero Spain	25	1.9k 0.9×	1.5k 0.9×	960 1.1×	306 1.6×	7 0.0×	91	2.5k
Shiv Lal India	21	755 0.4×	522 0.3×	228 0.3×	159 0.8×	21 0.1×	97	1.6k

Countries citing papers authored by Lorna Bozeman

Since Specialization

Citations

This map shows the geographic impact of Lorna Bozeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna Bozeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna Bozeman more than expected).

Fields of papers citing papers by Lorna Bozeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna Bozeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna Bozeman. The network helps show where Lorna Bozeman may publish in the future.

Co-authorship network of co-authors of Lorna Bozeman

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna Bozeman. A scholar is included among the top collaborators of Lorna Bozeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna Bozeman. Lorna Bozeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorman, Susan E., Radojka M. Savić, Stefan Goldberg, et al.. (2014). Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial. American Journal of Respiratory and Critical Care Medicine. 191(3). 333–343. 76 indexed citations

Heilig, Charles M., Moses Joloba, John L. Johnson, et al.. (2014). How we determined the most reliable solid medium for studying treatment of tuberculosis. Tuberculosis. 94(3). 317–322. 3 indexed citations

Reves, Randall, Charles M. Heilig, Lorna Bozeman, et al.. (2014). Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance. The International Journal of Tuberculosis and Lung Disease. 18(5). 571–580. 10 indexed citations

Nyendak, Melissa, Byung Park, Megan Null, et al.. (2013). Mycobacterium tuberculosis Specific CD8+ T Cells Rapidly Decline with Antituberculosis Treatment. PLoS ONE. 8(12). e81564–e81564. 37 indexed citations

Dorman, Susan E., Stefan Goldberg, Jason E. Stout, et al.. (2012). Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium. The Journal of Infectious Diseases. 206(7). 1030–1040. 85 indexed citations

Kenzie, William R. Mac, Charles M. Heilig, Lorna Bozeman, et al.. (2011). Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa. PLoS ONE. 6(4). e18358–e18358. 26 indexed citations

Samandari, Taraz, Tefera Agizew, Samba Nyirenda, et al.. (2011). 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. The Lancet. 377(9777). 1588–1598. 258 indexed citations

Sterling, Timothy R., Margarita E. Villarino, Andrey Borisov, et al.. (2011). Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection. New England Journal of Medicine. 365(23). 2155–2166. 630 indexed citations breakdown →

Dorman, Susan E., John L. Johnson, Stefan Goldberg, et al.. (2009). Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(3). 273–280. 184 indexed citations

10.

Burman, William J., Lauren S. Cowan, Lorna Bozeman, et al.. (2009). Relapse Associated with Active Disease Caused by Beijing Strain ofMycobacterium tuberculosis1. Emerging infectious diseases. 15(7). 1061–1067. 38 indexed citations

11.

Bozeman, Lorna, W. J. Burman, Beverly Metchock, Lindsay Welch, & Marc Weiner. (2005). Fluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada. Clinical Infectious Diseases. 40(3). 386–391. 51 indexed citations

12.

Jasmer, Robert M., Lorna Bozeman, Kevin Schwartzman, et al.. (2004). Recurrent Tuberculosis in the United States and Canada. American Journal of Respiratory and Critical Care Medicine. 170(12). 1360–1366. 105 indexed citations

13.

Benator, Debra, Mondira Bhattacharya, Lorna Bozeman, et al.. (2002). Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. The Lancet. 360(9332). 528–534. 297 indexed citations

14.

Vernon, Andrew, William J. Burman, Debra Benator, Awal Khan, & Lorna Bozeman. (1999). Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. The Lancet. 353(9167). 1843–1847. 227 indexed citations

15.

Spira, Thomas J., Lorna Bozeman, Donna T. Warfield, et al.. (1990). Lack of Correlation between Human Herpesvirus-6 Infection and the Course of Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 161(3). 567–570. 44 indexed citations

16.

Spira, Thomas J., Jonathan E. Kaplan, Robert C. Holman, et al.. (1989). Deterioration in immunologic status of human immunodeficiency virus (HIV)-infected homosexual men with lymphadenopathy: Prognostic implications. Journal of Clinical Immunology. 9(2). 132–138. 2 indexed citations

17.

Dykstra, Michael J., et al.. (1984). Investigations of budgerigar fledgling disease virus. American Journal of Veterinary Research. 45(9). 1883–1887. 3 indexed citations

18.

Dykstra, Michael J. & Lorna Bozeman. (1982). A light and electron microscopic examination of budgerigar fledgling disease virus in tissue and in cell culture. Avian Pathology. 11(1). 11–28. 34 indexed citations

19.

Bozeman, Lorna, et al.. (1981). A Viral Disease of Fledgling Budgerigars. Avian Diseases. 25(1). 179–179. 61 indexed citations

20.

Bozeman, Lorna, et al.. (1981). Characterization of a Papovavirus Isolated from Fledgling Budgerigars. Avian Diseases. 25(4). 972–972. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact